FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095194 [Registered on: 22/09/2025] Trial Registered Prospectively
Last Modified On: 19/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Role of Homoeopathy in the Treatment of Bronchial Asthma. 
Scientific Title of Study   Effect of Homoeopathic medicines in treatment of Bronchial Asthma using the Repertory 'Leaders in respiratory organs' by E B NASH: A prospective single arm study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhavna Rana 
Designation  PG Scholar 
Affiliation  Bakson Homoeopathic Medical College And Hospital 
Address  Room no B15 Department of Homoeopathic Repertory and Case taking Basement Floor Plot no 36B Knowledge Park Phase 1 Greater Noida Uttar Pradesh India 201306

Gautam Buddha Nagar
UTTAR PRADESH
201306
India 
Phone  9599170772  
Fax    
Email  ranabhavna760@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shailja Upadhyay 
Designation  Associate professor Department of Homoeopathic Repertory and Case Taking  
Affiliation  Bakson Homoeopathic Medical College And Hospital 
Address  Room no B15 Department of Homoeopathic Repertory and Case taking Basement Floor Plot no 36B Knowledge Park Phase 1 Greater Noida Uttar Pradesh India 201306

Gautam Buddha Nagar
UTTAR PRADESH
201306
India 
Phone  8447753501  
Fax    
Email  drshailjaupadhyay22@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aditi Goyal  
Designation  HOD Department of Homoeopathic Repertory and Case taking  
Affiliation  Bakson Homoeopathic Medical College And Hospital 
Address  Room no B15 Department of Homoeopathic Repertory and Case taking Basement Floor Plot no 36B Knowledge Park Phase 1 Greater Noida Uttar Pradesh India 201306

Gautam Buddha Nagar
UTTAR PRADESH
201306
India 
Phone  9910797598  
Fax    
Email  draditigoyal19@gmail.com  
 
Source of Monetary or Material Support  
Bakson Homoeopathic Medical College And Hospital Room no G 22 Principal office Ground floor Plot no 36B Knowledge Park Phase 1 Greater Noida Uttar Pradesh India 201306 
 
Primary Sponsor  
Name  Bakson Homoeopathic Medical College And Hospital 
Address  Room no G 22 Principal office Ground floor Plot no 36B Knowledge Park Phase 1 Greater Noida Uttar Pradesh India 201306 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhavna Rana  Bakson Homoeopathic Medical College And Hospital  Out Patient Department Room no 1 Ground floor Plot no 36 B Knowledge Park Phase 1 Greater Noida Uttar Pradesh
Gautam Buddha Nagar
UTTAR PRADESH 
9599170772

ranabhavna760@gmail.com 
Dr Bhavna Rana  Dr D P Rastogi Central Research Institute of Homoeopathy  General OPD room no 110 Ground Floor A 1/1 Opposite HCL Sector 24 Noida 201307
Gautam Buddha Nagar
UTTAR PRADESH 
9599170772

ranabhavna760@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee Bakson Homoeopathic Medical College  Approved 
Kendriya Homoeopathic Anusandhan Parishad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J455||Severe persistent asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic medicine  Pill form of administration Oral route of administration 30 pill size Centesimal scale First dose after case taking repetition of dose according to follow up every 4 weeks upto 24 weeks. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  59.00 Year(s)
Gender  Both 
Details  Subjects of age from 18-59 age group of all sexes.
Patients suffering from persistent acute and chronic bronchial asthma. 
 
ExclusionCriteria 
Details  Patients suffering from other severe systemic diseases.
Pregnant and lactating mothers.
Participants with any psychiatric illness. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the effectiveness of Homoeopathic Medicines
using repertory leaders in respiratory organ by E B Nash and change in severity of symptoms before and after the treatment using Asthma Quality Of Life Questionnaire With Standardise Activities in treatment of Bronchial Asthma. 
16 months study
6 months enrollment
6 months follow up
2 months data analysis
2 months report writing  
 
Secondary Outcome  
Outcome  TimePoints 

Nil 
Nil 
 
Target Sample Size   Total Sample Size="35"
Sample Size from India="35" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
To assess the effectiveness of Homoeopathic Medicines using repertory leaders in Respiratory organs by EB Nash and change in severity of symptoms before and after the treatment of bronchial asthma using AQLO scale. Scale will be assessed at baseline 12 weeks and 24 weeks. 35 cases will be enrolled and difference in the scores will be assessed using paired t test at baseline and 24 weeks.

 
Close